SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}
An SI Board Since January 1999
Posts SubjectMarks Bans
423 27 0
Emcee:  BRAVEHEART Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23 In regards to Memantine: What I am saying that If a drug had significant efficyosi s-1/16/1999
22 My general statement "I believe those which offer the highest degree of BRAVEHEART-1/16/1999
21 Yes yosi, A ten year treatment history in Europe. I assume you are familiar BRAVEHEART-1/16/1999
20 "I believe those which offer the highest degree of success with yosi s-1/16/1999
19 "Memantine has a 10 year treatment history for dementia in Europe. " yosi s-1/16/1999
18 Hi Larry, Good question. I believe those which offer the highest degree of sucBRAVEHEART-1/16/1999
17 SKIPPED phase 2 Companies may design a study that phase 2 is included in phasyosi s-1/16/1999
16 As a holder of SUGN, I was interested in which other molecules have jumped froLarry Liebman-1/15/1999
15 SCIOS UPDATE: { Compliments Linda Pearson } From TheStreet.Com yesterday: HBRAVEHEART-1/15/1999
14 LXR UPDATE: Hi Gang, Since my post on the 6th there have been two releases reBRAVEHEART-1/12/1999
13 SCIOS IS NOT NECESSARILY UNDERVALUED... However the excitement leading up to tBRAVEHEART-1/11/1999
12 H & Q conference hamquist.com messages.yahoo.com@m2.yahoo.comCPAMarty-1/10/1999
11 Congradulations to all on such an informative and well documented web site. BiWilliam Whitehead Jr.-1/9/1999
10 Hi Gang, I consider LXR another extremely undervalued Biotech. The stock tradBRAVEHEART-1/6/1999
9 Imclone (IMCL)(cancer research) has crossed its 50 and 200 day average dailysCPAMarty-1/5/1999
8 for more on Pharmos Message 7095766yosi s-1/4/1999
7 Pharmos PARS . pharmoscorp.com a small biotech. with 2 related product receyosi s-1/3/1999
6 Hi chalu2, I do not currently follow either CHAI or NSIX. The goal of this BRAVEHEART-1/3/1999
5 Thread: I'm becoming more enthusiastic about my remaining "one-third&qMike McFarland-1/3/1999
4 here is one that everyone should check out dimethaid research I have been n.p.-1/2/1999
3 Bio Technology General Corp (BTGC) finished 1998 up about $1 in two days to CPAMarty-1/2/1999
2 Braveheart, you seem very knowledgeable in this area--do you have any opinions chalu2-1/2/1999
1 Hi Gang, I consider NTII an extremely undervalued stock. This company startedBRAVEHEART-1/2/1999
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):